Volume-specific cutoffs are necessary for reproducible application of prostate-specific antigen density of the transition zone in prostate cancer detection

Urology

Volumn 58, Issue 2, 2001, Pages 222-226

  Taneja, Samir S ^a   Tran, Khoa ^a   Lepor, Herbert ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN SPECIFICITY; ARTICLE; BENIGN TUMOR; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; ORGAN SIZE; POPULATION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROTEIN BLOOD LEVEL; TUMOR BIOPSY;

BIOPSY; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034908872     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(01)01229-8     Document Type: Article

References (22)

1. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
2. Screening for prostatic carcinoma with prostate specific antigen
3. Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen
4. Prostate-specific antigen coordinated with digital rectal examination and transrectal ultrasonography in the detection of prostate cancer
5. Prostate specific antigen density of the transition zone for early detection of prostate cancer
6. Transition zone prostate specific antigen density: Lack of use in prediction of prostatic carcinoma
7. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer
8. Refining the gold standard - Can we do better with serum prostate specific antigen in the detection of prostate cancer?
9. Prostate specific antigen density: A means of distinguishing benign prostatic hypertrophy and prostate cancer
10. An algorithm for prostate cancer detection in a patient population using prostate-specific antigen and prostate-specific antigen density
11. Prospective evaluation of prostate-specific antigen density and systematic biopsies for early detection of prostatic carcinoma
12. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice
13. Serum PSA adjusted for volume of transition zone (PSAT) is more accurate than PSA adjusted for total gland volume (PSAD) in detecting adenocarcinoma of the prostate
14. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening
15. Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: A prospective multicenter clinical trial
16. Prostate specific antigen density of the transition zone: A new effective parameter for prostate cancer prediction
17. Prostate specific antigen density of the transition zone for predicting pathological stage of localized prostate cancer in patients with serum prostate specific antigen less than 10 ng./ml
18. PSA density (PSAD): Role in patient evaluation and management
19. The lack of predictive value of prostate specific antigen density in the detection of prostate cancer in patients with normal rectal examinations and intermediate prostate specific antigen levels
20. The inability of prostate specific antigen index to enhance the predictive value of prostate specific antigen in the diagnosis of prostatic carcinoma
21. Relationship between prostatic epithelial volume and serum prostate-specific antigen levels
22. Total and transition zone prostate volume and age: How do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?